{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:45:59Z","timestamp":1784825159191,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116871","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T17:37:38Z","timestamp":1726249058000},"page":"116871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Peptides as modulators of FPPS enzyme: A multifaceted evaluation from the design to the mechanism of action"],"prefix":"10.1016","volume":"279","author":[{"given":"Verdiana","family":"Covelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Buonocore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Scrima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"van Baarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Biscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmina","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Matteoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"D'Ursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Rodriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116871_bib1","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1021\/acs.jmedchem.9b01405","article-title":"Farnesyl pyrophosphate synthase as a target for drug development: discovery of natural-product-derived inhibitors and their activity in pancreatic cancer cells","volume":"62","author":"Han","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/17460441.2016.1143814","article-title":"Approaches for designing new potent inhibitors of farnesyl pyrophosphate synthase","volume":"11","author":"Rodriguez","year":"2016","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116871_bib3","first-page":"80","article-title":"Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design, Proteins: structure, Function","volume":"62","author":"Gabelli","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2024.116871_bib4","doi-asserted-by":"crossref","first-page":"15197","DOI":"10.1021\/bi061572k","article-title":"Structure and reaction geometry of geranylgeranyl diphosphate synthase from Sinapis alba","volume":"45","author":"Kloer","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116871_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cmdc.200500059","article-title":"Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs","volume":"1","author":"Rondeau","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116871_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1472-6807-12-32","article-title":"Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme's active site closure","volume":"12","author":"Park","year":"2012","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.ejmech.2024.116871_bib7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nchembio.421","article-title":"Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery","volume":"6","author":"Jahnke","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116871_bib8","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1074\/jbc.C300511200","article-title":"Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis","volume":"279","author":"Hosfield","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14132","article-title":"Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product","volume":"8","author":"Park","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116871_bib10","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0022-2275(20)41388-4","article-title":"Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis","volume":"33","author":"Amin","year":"1992","journal-title":"Journal of lipid research"},{"key":"10.1016\/j.ejmech.2024.116871_bib11","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1021\/jm400946f","article-title":"Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition","volume":"56","author":"Leung","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib12","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2024.116871_bib13","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.ejca.2004.03.025","article-title":"Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer","volume":"40","author":"Diel","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116871_bib14","article-title":"Phosphonate and bisphosphonate inhibitors of farnesyl pyrophosphate synthases: a structure-guided perspective","volume":"8","author":"Park","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib15","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1021\/jm500629e","article-title":"Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases","volume":"57","author":"De Schutter","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","article-title":"Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo","volume":"165","author":"Francis","year":"1969","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2024.116871_bib17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/ijc.24056","article-title":"N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1","volume":"124","author":"Laezza","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2024.116871_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.279","article-title":"p53 regulates the mevalonate pathway in human glioblastoma multiforme","volume":"6","author":"Laezza","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116871_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/1871520611313040016","article-title":"N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells","volume":"13","author":"Castiglioni","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib20","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1021\/jm500869x","article-title":"Structural evidence of N6-isopentenyladenosine as a new ligand of farnesyl pyrophosphate synthase","volume":"57","author":"Scrima","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib21","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/bph.13824","article-title":"The isoprenoid derivative N(6) -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway","volume":"174","author":"Ciaglia","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116871_bib22","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.3390\/molecules26237146","article-title":"Towards an improvement of anticancer activity of benzyl adenosine analogs","volume":"26","author":"Covelli","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116871_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103449","article-title":"NMR for screening and a biochemical assay: identification of new FPPS inhibitors exerting anticancer activity","volume":"98","author":"Grimaldi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future?","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib25","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.2174\/09298673113209990184","article-title":"From peptides to small molecules: an intriguing but intricated way to new drugs","volume":"20","author":"Scognamiglio","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib26","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030681","article-title":"A new approach to supramolecular structure determination in pharmaceutical preparation of self-assembling peptides: a case study of lanreotide autogel","volume":"14","author":"Grimaldi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2024.116871_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11568","article-title":"Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD\/ACE2 binding site","volume":"8","author":"Buonocore","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2024.116871_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114400","article-title":"New Abeta(1-42) ligands from anti-amyloid antibodies: design, synthesis, and structural interaction","volume":"237","author":"Santoro","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115610","article-title":"Exploiting the features of short peptides to recognize specific cell surface markers","volume":"24","author":"Buonocore","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116871_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cbpa.2008.09.023","article-title":"Peptides as protein binding site mimetics","volume":"12","author":"Eichler","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116871_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2024.116871_bib33","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.123.001074","article-title":"Pharmacometabolomics in drug disposition, toxicity and precision medicine","author":"Trevor","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116871_bib34","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.apsb.2023.05.021","article-title":"Metabolomics in drug research and development: the recent advances in technologies and applications","volume":"13","author":"Pang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2024.116871_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actbio.2019.02.017","article-title":"Oxidized alginate hydrogels with the GHK peptide enhance cord blood mesenchymal stem cell osteogenesis: a paradigm for metabolomics-based evaluation of biomaterial design","volume":"88","author":"Klontzas","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejmech.2024.116871_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","article-title":"The mevalonate pathway is a druggable target for vaccine adjuvant discovery","volume":"175","author":"Xia","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116871_bib37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bmcl.2014.12.089","article-title":"Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase","volume":"25","author":"Gritzalis","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116871_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm.2015.11","article-title":"Protein prenylation: unique fats make their mark on biology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116871_bib39","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib40","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Solid phase peptide synthesis. I. The synthesis of a tetrapeptide","volume":"85","author":"Merrifield","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116871_bib41","doi-asserted-by":"crossref","first-page":"32658","DOI":"10.1039\/C4RA02458C","article-title":"Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides","volume":"4","author":"Palomo","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116871_bib42","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1039\/D0OB00499E","article-title":"Multiphosphorylated peptides: importance, synthetic strategies, and applications for studying biological mechanisms","volume":"18","author":"Samarasimhareddy","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10989-007-9107-y","article-title":"Synthesis of phosphopeptides in the Fmoc mode","volume":"13","author":"Attard","year":"2007","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116871_bib44","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q","article-title":"Characterization of ligand binding by saturation transfer difference NMR spectroscopy","volume":"38","author":"Mayer","year":"1999","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib45","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1021\/ja0100120","article-title":"Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor","volume":"123","author":"Mayer","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116871_bib46","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00249-011-0749-5","article-title":"STD-NMR: application to transient interactions between biomolecules-a quantitative approach","volume":"40","author":"Angulo","year":"2011","journal-title":"Eur. Biophys. J. : EBJ (Eur. Biophys. J.)"},{"key":"10.1016\/j.ejmech.2024.116871_bib47","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1021\/bi201284u","article-title":"The original Michaelis constant: translation of the 1913 Michaelis\u2013Menten paper","volume":"50","author":"Johnson","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116871_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14495-6","article-title":"Deregulated expression and activity of farnesyl diphosphate synthase (FDPS) in glioblastoma","volume":"7","author":"Abate","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116871_bib49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000082918","article-title":"Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis","volume":"67","author":"Notarnicola","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.ejmech.2024.116871_bib50","first-page":"2585","article-title":"A significant role of lipogenic enzymes in colorectal cancer","volume":"32","author":"Notarnicola","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2024.116871_bib51","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s10495-008-0211-z","article-title":"The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis","volume":"13","author":"Sewing","year":"2008","journal-title":"Apoptosis : an international journal on programmed cell death"},{"key":"10.1016\/j.ejmech.2024.116871_bib52","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.116871_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10994-008-5070-x","article-title":"A critical analysis of variants of the AUC","volume":"72","author":"Vanderlooy","year":"2008","journal-title":"Mach. Learn."},{"key":"10.1016\/j.ejmech.2024.116871_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","article-title":"InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams","volume":"16","author":"Heberle","year":"2015","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejmech.2024.116871_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0303-2647(98)00017-3","article-title":"Computation with the KEGG pathway database","volume":"47","author":"Ogata","year":"1998","journal-title":"Biosystems"},{"key":"10.1016\/j.ejmech.2024.116871_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092301","article-title":"Response of cisplatin resistant skov-3 cells to [Pt(O,O'-Acac)(\u03b3-Acac)(DMS)] treatment revealed by a metabolomic 1H-NMR study","volume":"23","author":"De Castro","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116871_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/metabo3030552","article-title":"A review of applications of metabolomics in cancer","volume":"3","author":"Beger","year":"2013","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2024.116871_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626971","article-title":"The mevalonate pathway, a metabolic target in cancer therapy","volume":"11","author":"Guerra","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2024.116871_bib59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1574892812666171129141211","article-title":"Targeting mevalonate pathway in cancer treatment: repurposing of statins","volume":"13","author":"Iannelli","year":"2018","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116871_bib60","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.18632\/oncotarget.6304","article-title":"Simvastatin-induced breast cancer cell death and deactivation of PI3K\/Akt and MAPK\/ERK signalling are reversed by metabolic products of the mevalonate pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116871_bib61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00253-019-10257-8","article-title":"Targeting PI3K\/AKT\/mTOR-mediated autophagy for tumor therapy","volume":"104","author":"Xu","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116871_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib63","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib64","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116871_bib65","series-title":"Schr\u00f6dinger Release 2021-4: Maestro","author":"Schr\u00f6dinger","year":"2021"},{"key":"10.1016\/j.ejmech.2024.116871_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2024.116871_bib67","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(70)90146-6","article-title":"Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides","volume":"34","author":"Kaiser","year":"1970","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2024.116871_bib68","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10858-019-00285-x","article-title":"A simple protocol for expression of isotope-labeled proteins in Escherichia coli grown in shaker flasks at high cell density","volume":"73","author":"Cai","year":"2019","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.ejmech.2024.116871_bib69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2024.116871_bib70","series-title":"G. Prism","year":"1994"},{"key":"10.1016\/j.ejmech.2024.116871_bib71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cmr.a.20223","article-title":"How the 1D\u2010NOESY suppresses solvent signal in metabonomics NMR spectroscopy: an examination of the pulse sequence components and evolution","volume":"38","author":"McKay","year":"2011","journal-title":"Concepts Magn. Reson."},{"key":"10.1016\/j.ejmech.2024.116871_bib72","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jmr.2007.05.008","article-title":"Robust baseline correction algorithm for signal dense NMR spectra","volume":"187","author":"Chang","year":"2007","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.ejmech.2024.116871_bib73","first-page":"36","article-title":"NMRProcFlow: a graphical and interactive tool dedicated to 1D spectra processing for NMR-based metabolomics, Metabolomics","volume":"13","author":"Jacob","year":"2017","journal-title":"Official journal of the Metabolomic Society"},{"key":"10.1016\/j.ejmech.2024.116871_bib74","first-page":"92","article-title":"Multivariate analysis in metabolomics","volume":"1","author":"Worley","year":"2013","journal-title":"Current Metabolomics"},{"key":"10.1016\/j.ejmech.2024.116871_bib75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2214\/ajr.184.2.01840364","article-title":"ROC analysis, AJR","volume":"184","author":"Obuchowski","year":"2005","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejmech.2024.116871_bib76","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recogn. Lett."},{"key":"10.1016\/j.ejmech.2024.116871_bib77","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkm882","article-title":"KEGG for linking genomes to life and the environment","volume":"36","author":"Kanehisa","year":"2008","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T20:40:35Z","timestamp":1731271235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424007529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":77,"alternative-id":["S0223523424007529"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116871","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptides as modulators of FPPS enzyme: A multifaceted evaluation from the design to the mechanism of action","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116871"}}